Leave a Message
+86 21 52992719

About Us

Science-driven, Innovation-led,
Craftsmen of Proteins, Uniquely Empowered
Company Overview

Yinjia (Shanghai) Biosciences,founded in 2020 and headquartered in Shanghai, has established the proteins and detection kits R&D and pilot scale-production bases located in the Shanghai Lingang Pujiang International Advanced Manufacturing Industrial Base and in the Beijing E-Town Economic Development Zone, as well as a GMP production platform in Suzhou Industrial Park. As an AI-driven developer and manufacturer focusing on high-end protein raw materials and quality control and safety evaluation detection reagents for therapeutic biologics, our technical team is composed by a group of well-trained Ph.D. and masters with rich experience in pharma/biotech/top tier CRO settings.

To date, Yinjia Bio has completed three rounds of financing totaling a couple of hundreds of millions of RMB, led by top investment institutions such as CDH Investments, Gaorong Capital, and CMB International. The company has built four key platforms: (1) a relatively complete high-end protein (antigen, antibody, enzyme and special protein) development platform for intelligent design and complex process development; (2) a detection reagent development platform for the quality control and evaluation system of therapeutic biological products; (3) a high-throughput cell-free protein expression system enabling AI protein prediction and design; (4) a synthetic biology technology platform based on microbial chassis cell modification and protein engineering structure modification capabilities. Leveraging these unique platforms, we have successfully developed hundreds of products comparable to imported ones, covering biomedicine fields such as ADC new drug R&D, vaccine production, cell therapy, organoids and proteomics. It has continuously provided high-quality and stable products for listed pharmaceutical companies, innovative pharmaceutical companies, listed diagnostic companies and scientific research institutes.

Yinjia Bio adheres to the philosophy of "Innovation, Quality, Service." We will continue to integrate cross‑disciplinary cutting‑edge science and advanced technologies, strengthen our core competitiveness in foundational technologies, combine our professional and efficient product development capabilities with a sound quality management system, and continuously enhance technological innovation and product quality to meet the needs of our customers and the market, thereby fulfilling Yinjia Bio's mission and original aspiration.

Upholding the core values of Innovation, Quality and Service, Yinjia Bio continuously integrates interdisciplinary frontier sciences and advanced technologies to consolidate fundamental core technological competitiveness. Supported by our professional and efficient product development capabilities and a comprehensive quality management system, we steadily advance technological innovation and iterative product optimization. We strive to fully meet customer and market demands, and fulfill our original mission and long-term vision.

  • 6+
    Established in 2020
  • 20+
    Nationwide Service Network
  • 22+
    Patents Granted
  • 200+
    Partners
Awards

Yinjia Bio was recognized as a "Specialized and New" Small and Medium-sized Enterprise and ISO9001 Certification in 2023.

Additionally, we were selected into the 2023 Future Healthcare top 100 supplier List and the 2022 CHC-CITIC Securities Most Investable Healthcare Enterprise List.